Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $4.29B.
ENTERPRISE VALUE (EV)
$4.29B
Edgewise Therapeutics, Inc.
Market Cap
$4.35B
Enterprise Value (EV)
$4.29B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | $4.35B | $4.29B |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.38B | $4.37B |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.41B | $4.70B |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.43B | $4.67B |
| LivaNova PLC (LIVN)vs › | $4.13B | $3.96B |
| AbCellera Biologics Inc. (ABCL)vs › | $4.06B | $4.07B |
| BillionToOne, Inc. (BLLN)vs › | $4.64B | $4.24B |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | $5.72B |
| LifeStance Health Group, Inc. (LFST)vs › | $4.65B | $4.63B |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.68B | $4.06B |
Market Cap
$4.35B
Total Debt
$2.98M
Cash
$61.15M
Enterprise Value
$4.29B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
